These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25630683)

  • 1. Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.
    Schümann J; Grevot A; Ledieu D; Wolf A; Schubart A; Piaia A; Sutter E; Côté S; Beerli C; Pognan F; Billich A; Moulin P; Walker UJ
    Toxicol Pathol; 2015 Jul; 43(5):694-703. PubMed ID: 25630683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
    Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
    Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice.
    Jeon S; Song J; Lee D; Kim GT; Park SH; Shin DY; Shin KO; Park K; Shim SM; Park TS
    J Lipid Res; 2020 Jan; 61(1):20-32. PubMed ID: 31690639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
    Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
    Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts.
    Ihlefeld K; Claas RF; Koch A; Pfeilschifter JM; Meyer Zu Heringdorf D
    Biochem J; 2012 Nov; 447(3):457-64. PubMed ID: 22908849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
    Bagdanoff JT; Donoviel MS; Nouraldeen A; Tarver J; Fu Q; Carlsen M; Jessop TC; Zhang H; Hazelwood J; Nguyen H; Baugh SD; Gardyan M; Terranova KM; Barbosa J; Yan J; Bednarz M; Layek S; Courtney LF; Taylor J; Digeorge-Foushee AM; Gopinathan S; Bruce D; Smith T; Moran L; O'Neill E; Kramer J; Lai Z; Kimball SD; Liu Q; Sun W; Yu S; Swaffield J; Wilson A; Main A; Carson KG; Oravecz T; Augeri DJ
    J Med Chem; 2009 Jul; 52(13):3941-53. PubMed ID: 19489538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.
    Maeda Y; Yagi H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Masuko T; Chiba K
    Int Immunol; 2014 May; 26(5):245-55. PubMed ID: 24343820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss.
    Weske S; Vaidya M; Reese A; von Wnuck Lipinski K; Keul P; Bayer JK; Fischer JW; Flögel U; Nelsen J; Epple M; Scatena M; Schwedhelm E; Dörr M; Völzke H; Moritz E; Hannemann A; Rauch BH; Gräler MH; Heusch G; Levkau B
    Nat Med; 2018 May; 24(5):667-678. PubMed ID: 29662200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
    Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
    Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyase to live by: sphingosine phosphate lyase as a therapeutic target.
    Kumar A; Saba JD
    Expert Opin Ther Targets; 2009 Aug; 13(8):1013-25. PubMed ID: 19534571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural sphingosine 1-phosphate accumulation activates microglia and links impaired autophagy and inflammation.
    Karunakaran I; Alam S; Jayagopi S; Frohberger SJ; Hansen JN; Kuehlwein J; Hölbling BV; Schumak B; Hübner MP; Gräler MH; Halle A; van Echten-Deckert G
    Glia; 2019 Oct; 67(10):1859-1872. PubMed ID: 31231866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake.
    Peest U; Sensken SC; Andréani P; Hänel P; Van Veldhoven PP; Gräler MH
    J Cell Biochem; 2008 Jun; 104(3):756-72. PubMed ID: 18172856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
    Weiler S; Braendlin N; Beerli C; Bergsdorf C; Schubart A; Srinivas H; Oberhauser B; Billich A
    J Med Chem; 2014 Jun; 57(12):5074-84. PubMed ID: 24809814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme.
    Ikeda M; Kihara A; Kariya Y; Lee YM; Igarashi Y
    Biochem Biophys Res Commun; 2005 Apr; 329(2):474-9. PubMed ID: 15737611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors.
    Loetscher E; Schneider K; Beerli C; Billich A
    Biochem Biophys Res Commun; 2013 Apr; 433(3):345-8. PubMed ID: 23499842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions.
    Vogel P; Donoviel MS; Read R; Hansen GM; Hazlewood J; Anderson SJ; Sun W; Swaffield J; Oravecz T
    PLoS One; 2009; 4(1):e4112. PubMed ID: 19119317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of S1P Lyase Expression in Human Podocytes Causes a Reduction in Nephrin Expression That Involves PKCδ Activation.
    Imeri F; Stepanovska Tanturovska B; Manaila R; Pavenstädt H; Pfeilschifter J; Huwiler A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol.
    Ikeda M; Kihara A; Igarashi Y
    Biochem Biophys Res Commun; 2004 Dec; 325(1):338-43. PubMed ID: 15522238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis.
    Kariya Y; Kihara A; Ikeda M; Kikuchi F; Nakamura S; Hashimoto S; Choi CH; Lee YM; Igarashi Y
    Genes Cells; 2005 Jun; 10(6):605-15. PubMed ID: 15938718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.